Ginkgo Bioworks Holdings, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 19.5M | 33.4M | 38.8M | 49.6M | 48.3M | 43.8M | 89.0M | 56.2M |
| Cost of Goods Sold | 15.9M | -8.2M | 12.8M | 14.8M | 12.0M | 9.6M | 10.0M | 13.7M |
| Gross Profit | 3.6M | 41.5M | 26.0M | 34.8M | 36.3M | 34.2M | 79.1M | 42.5M |
| R&D Expenses | 49.9M | 50.1M | 69.4M | 53.4M | 70.9M | 76.4M | 77.0M | 134.2M |
| Operating Expenses | 75.0M | 112.3M | 116.1M | 100.3M | 125.2M | 137.8M | 134.3M | 265.4M |
| Operating Income | -71.4M | -70.8M | -90.0M | -65.5M | -89.0M | -103.6M | -55.2M | -222.9M |
| Other Income / Gains | -4.8M | -10.6M | 9.3M | 5.0M | -1.9M | -4.3M | -1.6M | 6.0M |
| Net Income | -82.6M | -80.8M | -80.8M | -60.3M | -91.0M | -107.5M | -56.4M | -217.2M |
| EPS (Diluted) | -1.39 | -1.43 | -1.45 | -1.10 | -1.68 | -2.07 | -1.08 | -4.23 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.184 | 1.244 | 0.67 | 0.701 | 0.751 | 0.781 | 0.888 | 0.756 |
| General And Administrative Expenses | 37.8M | 46.0M | 45.0M | 43.3M | 49.0M | 57.3M | 52.3M | 66.3M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 37.8M | 46.0M | 45.0M | 43.3M | 49.0M | 57.3M | 52.3M | 66.3M |
| Other Expenses | -12.8M | 16.2M | 1.7M | 3.7M | 5.3M | 4.2M | 5.0M | 64.9M |
| Cost And Expenses | 90.8M | 104.1M | 128.9M | 115.1M | 137.3M | 147.5M | 144.3M | 279.2M |
| Interest Income | 3.6M | 40.9M | 5.7M | 6.1M | 6.1M | 7.3M | 9.3M | 10.3M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 94K | 0 | 0 |
| Depreciation And Amortization | 12.8M | 46.5M | 14.2M | 15.8M | 15.4M | 15.7M | 17.2M | 17.3M |
| Ebitda | -58.6M | -34.9M | -66.6M | -46.1M | -68.3M | -143.5M | -35.1M | -140.7M |
| Ebitdaratio | -3.008 | -1.044 | -1.714 | -0.929 | -1.414 | -3.272 | -0.394 | -2.503 |
| Operating Income Ratio | -3.665 | -2.119 | -2.318 | -1.321 | -1.841 | -2.363 | -0.62 | -3.967 |
| Income Before Tax | -76.1M | -81.4M | -80.8M | -60.6M | -90.9M | -107.9M | -56.8M | -217.0M |
| Income Before Tax Ratio | -3.91 | -2.437 | -2.079 | -1.221 | -1.881 | -2.46 | -0.638 | -3.861 |
| Income Tax Expense | -80K | -643K | 1K | -283K | 88K | -325K | -375K | 190K |
| Net Income Ratio | -4.241 | -2.418 | -2.079 | -1.216 | -1.882 | -2.452 | -0.633 | -3.864 |
| Epsdiluted | -1.39 | -1.43 | -1.45 | -1.10 | -1.68 | -2.07 | -1.08 | -4.23 |
| Weighted Average Shs Out | 59.6M | 55.5M | 55.6M | 54.9M | 54.2M | 51.9M | 52.2M | 51.3M |
| Weighted Average Shs Out Dil | 59.6M | 55.5M | 55.6M | 54.9M | 54.2M | 51.9M | 52.2M | 51.4M |